269 related articles for article (PubMed ID: 10986053)
1. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins.
Plaat BE; Hollema H; Molenaar WM; Torn Broers GH; Pijpe J; Mastik MF; Hoekstra HJ; van den Berg E; Scheper RJ; van der Graaf WT
J Clin Oncol; 2000 Sep; 18(18):3211-20. PubMed ID: 10986053
[TBL] [Abstract][Full Text] [Related]
2. Expression of P-glycoprotein, multidrug resistance-associated protein 1, and lung resistance-related protein in human soft tissue sarcomas before and after hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
Komdeur R; Plaat BE; Hoekstra HJ; Molenaar WM; Hollema H; van den Berg E; Mastik MF; van der Graaf WT
Cancer; 2001 May; 91(10):1940-8. PubMed ID: 11346877
[TBL] [Abstract][Full Text] [Related]
3. Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein.
Alexander D; Yamamoto T; Kato S; Kasai S
Surg Today; 1999; 29(5):401-6. PubMed ID: 10333409
[TBL] [Abstract][Full Text] [Related]
4. Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.
Komdeur R; Plaat BE; van der Graaf WT; Hoekstra HJ; Hollema H; van den Berg E; Zwart N; Scheper RJ; Molenaar WM
Eur J Cancer; 2003 May; 39(7):909-16. PubMed ID: 12706359
[TBL] [Abstract][Full Text] [Related]
5. Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.
Diestra JE; Condom E; Del Muro XG; Scheffer GL; Pérez J; Zurita AJ; Muñoz-Seguí J; Vigués F; Scheper RJ; Capellá G; Germà-Lluch JR; Izquierdo MA
J Urol; 2003 Oct; 170(4 Pt 1):1383-7. PubMed ID: 14501774
[TBL] [Abstract][Full Text] [Related]
6. Membrane transport proteins associated with drug resistance expressed in human melanoma.
Schadendorf D; Makki A; Stahr C; van Dyck A; Wanner R; Scheffer GL; Flens MJ; Scheper R; Henz BM
Am J Pathol; 1995 Dec; 147(6):1545-52. PubMed ID: 7495278
[TBL] [Abstract][Full Text] [Related]
7. Expression of P-glycoprotein and metallothionein in gastrointestinal stromal tumor and leiomyosarcomas. Clinical implications.
Pérez-Gutiérrez S; González-Cámpora R; Amérigo-Navarro J; Beato-Moreno A; Sánchez-León M; Pareja Megía JM; Virizuela-Echaburu JA; López-Beltrán A
Pathol Oncol Res; 2007; 13(3):203-8. PubMed ID: 17922049
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance proteins in gastrointestinal stromal tumors: site-dependent expression and initial response to imatinib.
Théou N; Gil S; Devocelle A; Julié C; Lavergne-Slove A; Beauchet A; Callard P; Farinotti R; Le Cesne A; Lemoine A; Faivre-Bonhomme L; Emile JF
Clin Cancer Res; 2005 Nov; 11(21):7593-8. PubMed ID: 16278376
[TBL] [Abstract][Full Text] [Related]
9. Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells.
Meschini S; Calcabrini A; Monti E; Del Bufalo D; Stringaro A; Dolfini E; Arancia G
Int J Cancer; 2000 Sep; 87(5):615-28. PubMed ID: 10925353
[TBL] [Abstract][Full Text] [Related]
10. [Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma].
Katsaros D; Fracchioli S; Arts HJ; de Vries EG; Danese S; Richiardi G; Arisio R; Gordini G; Van der Zee AG; Suurmeijer AJ; Massobrio M
Minerva Ginecol; 1999 Dec; 51(12):463-70. PubMed ID: 10767994
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of chemoresistance markers in women with epithelial ovarian carcinoma.
Goff BA; Paley PJ; Greer BE; Gown AM
Gynecol Oncol; 2001 Apr; 81(1):18-24. PubMed ID: 11277644
[TBL] [Abstract][Full Text] [Related]
12. Low-level doxorubicin resistance in benzo[a]pyrene-treated KB-3-1 cells is associated with increased LRP expression and altered subcellular drug distribution.
Cheng SH; Lam W; Lee AS; Fung KP; Wu RS; Fong WF
Toxicol Appl Pharmacol; 2000 Apr; 164(2):134-42. PubMed ID: 10764626
[TBL] [Abstract][Full Text] [Related]
13. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
den Boer ML; Pieters R; Kazemier KM; Rottier MM; Zwaan CM; Kaspers GJ; Janka-Schaub G; Henze G; Creutzig U; Scheper RJ; Veerman AJ
Blood; 1998 Mar; 91(6):2092-8. PubMed ID: 9490695
[TBL] [Abstract][Full Text] [Related]
14. Expression of multidrug resistance protein and messenger RNA correlate with (99m)Tc-MIBI imaging in patients with lung cancer.
Zhou J; Higashi K; Ueda Y; Kodama Y; Guo D; Jisaki F; Sakurai A; Takegami T; Katsuda S; Yamamoto I
J Nucl Med; 2001 Oct; 42(10):1476-83. PubMed ID: 11585860
[TBL] [Abstract][Full Text] [Related]
15. Expression of drug resistance related proteins in sarcomas of the pulmonary artery and poorly differentiated leiomyosarcomas of other origin.
Gaumann A; Tews DS; Mentzel T; Petrow PK; Mayer E; Otto M; Kirkpatrick CJ; Kriegsmann J
Virchows Arch; 2003 Jun; 442(6):529-37. PubMed ID: 12743815
[TBL] [Abstract][Full Text] [Related]
16. Pediatric gastrointestinal stromal tumors and leiomyosarcoma.
Cypriano MS; Jenkins JJ; Pappo AS; Rao BN; Daw NC
Cancer; 2004 Jul; 101(1):39-50. PubMed ID: 15221987
[TBL] [Abstract][Full Text] [Related]
17. Expression of proteins associated with therapy resistance in rhabdomyosarcoma and neuroblastoma tumour cells.
Pituch-Noworolska A; Zaremba M; Wieczorek A
Pol J Pathol; 2009; 60(4):168-73. PubMed ID: 20072950
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance proteins in primary and metastatic soft-tissue sarcomas: down-regulation of P-glycoprotein during metastatic progression.
Komdeur R; Molenaar WM; Zwart N; Hoekstra HJ; van den Berg E; van der Graaf WT
Anticancer Res; 2004; 24(1):291-5. PubMed ID: 15015610
[TBL] [Abstract][Full Text] [Related]
19. Drug retention, efflux, and resistance in tumor cells.
Krishan A; Fitz CM; Andritsch I
Cytometry; 1997 Dec; 29(4):279-85. PubMed ID: 9415409
[TBL] [Abstract][Full Text] [Related]
20. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
